Special Offers & Promotions



Latest News



View Channel

New Products



View Channel

Video Presentations



View Channel

Separation Science



View Channel

Microscopy & Image Analysis



View Channel

Laboratory Automation & IT Solutions



View Channel


Gyros Protein Technologies introduces PurePep Sonata+ peptide synthesizer

publication date: Apr 29, 2022
author/source: Gyros AB


Next-generation mid-pilot scale peptide synthesizer provides more reliable, robust, and improved workflows

Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today announced the launch of PurePep® Sonata®+, a mid-pilot scale peptide synthesizer. The new system is an upgraded version of the Company’s previous model, Sonata® XT, known for its reliability and robustness, to further strengthen the Company’s offering.

The upgrade, PurePep Sonata+, builds on the ability of Sonata XT through the introduction of real-time flow technology, a non-invasive method to continually monitor the flow rate of fluids within the system, which enables accurate and precise fluid transfers for a range of viscosities. The need to calibrate is thereby minimised, and workflows that previously required one day for fluid calibration are significantly shortened. The Company’s proprietary valve block system, the PurePep Pathway, is also integrated to ensure no cross-contamination, for reliable peptide purity. With a reduced calibration time to streamline and shorten workflows, improved reliability and robustness, the new peptide synthesizer is easy to operate, and the intuitive software platform, designed for 21 CFR Part 11 compliance, facilitates an easy transition from the bench scale PurePep® Chorus to mid-pilot scale.

Mark Vossenaar, Vice President, General Manager, Gyros Protein Technologies, commented: “The introduction of PurePep Sonata+ represents our commitment to building on the Company’s proven expertise and heritage to implement innovative technologies that continue to improve performance. With new intuitive software and hardware improvements, PurePep Sonata+ is much easier to operate and offers even greater reliability than Sonata XT, reinforcing confidence in our peptide synthesizers for research and development.”

Beta site scientist, added: “We beta-tested PurePep Sonata+ and found the platform easy-to-use whilst yielding robust, reliable results. The reduced calibration is a great improvement and, with software that allows us to program new syntheses as we run another, it is an invaluable asset for delivering high purity peptides more quickly.”



About Gyros Protein Technologies

Gyros Protein Technologies enables bioanalytical solutions and peptide synthesis, helping scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications. Proprietary high performance nanoliter-scale immunoassay platforms, Gyrolab xPand, and Gyrolab xPlore™, and Gyrolab immunoassay kits are used by scientists at leading pharmaceutical, biotech, CRO, and CMO companies in the development and manufacturing of various biotherapies including those based on peptides, antibodies, cell and gene therapies and vaccines. Gyrolab immunoassays provide key workflow advantages of speed, automation, and low reagent usage, and assay quality advantages of wide dynamic range with robust precision and reproducibility in applications including pharmacokinetics/pharmacodynamics, immunogenicity, and analysis of bioprocess-related impurities.

Our low to mid-scale peptide synthesizer platforms, PurePep® Chorus, Symphony® X, and PurePep® Sonata+, and chemistries deliver uncompromising purity, flexibility, and quality synthesis for discovery and pre-clinical studies of simple to complex multifunctional peptides. Our peptide synthesis and bioanalytical solutions accelerate the discovery, development, and manufacturing of safer biotherapeutics. Gyros Protein Technologies is part of the Biopharmaceutical Development Division of Mesa Laboratories, Inc. (Nasdaq: MLAB).



Recent news from Gyros Protein Technologies


If you have not logged into the website then please enter your details below.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month

Top 10 most popular articles this month



Today's Picks



Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners


Exhibitions & Events